Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at Castle Biosciences, InnoSign, EditCo

Castle Biosciences: Rodney Cotton, Mara Aspinall

Castle Biosciences has appointed Rodney Cotton to its board of directors. Cotton worked for more than two decades at Roche, most recently serving as senior VP, head of strategy and transformation, and chief of staff to the CEO for Roche Diagnostics. He currently serves on the board of directors of Eisai Pharmaceutical US and Orchard Software. Cotton is also an advisory board member for Flo2 Ventures. He holds an MBA from California State University, Dominguez Hills; an M.S. in strategic management from the University of Southern California; and a B.A. in biological sciences and technology from the University of California at Santa Barbara.

Castle also noted that current board member Mara Aspinall will not stand for reelection and her term will expire at the company's annual meeting in May.

InnoSign: Eric Lindquist, Paul van de Wiel

Eric Lindquist has been appointed as CEO of InnoSign, a Dutch company offering an mRNA-based pathway activity profiling test called OncoSignal. He will replace cofounder Paul van de Wiel as CEO, who will remain as chief operating officer and a board observer. Lindquist previously served as chief business and chief commercial officer at biotechnology firm Celcuity. Before that, he was global VP of the oncology and transplant business and commercial development at Natera. He also worked in business development, sales, and marketing at Cynvenio Biosystems, Asuragen, HTG Molecular Diagnostics, Roche, Apocell, J&J Life Sciences, and Abbott Laboratories. He holds a B.S. in genetics and cell biology from the University of Minnesota and an MBA from Capella University.

EditCo Bio: John Tan, Travis Maures

John Tan has been appointed CEO and Travis Maures CSO of Synthego gene editing spinoff EditCo Bio. Tan is the former president and chief operating officer, and Maures the former chief technology officer of Synthego.

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.